 | • レポートコード：MRC2Q12-03125 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、リスペリドンAPIの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にリスペリドンAPIのグローバル市場のxxx％を占める「98%以上」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「錠剤」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 リスペリドンAPIの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのリスペリドンAPI市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 リスペリドンAPIのグローバル主要プレイヤーには、Interquim SA、Inke S.A、Jai Radhe Sales、Dr. Reddy's Laboratories、Mylan、Teva、RPG Life Sciences Ltd.、Wuxi Jida Pharmaceutical Co., Ltd.、Venkata Narayana Active Ingredients、Torrent Pharmaceuticals Limited、Zhejiang Huahai Pharmaceutical、Icrom、Jubilant Generics、Jeil Pharmaceutical Co., Ltd、Aurobindo Pharma Limited、Enaltec Labs Private Limited、Anugraha Chemicals、Otto Brandes、Aurore Life Sciences、Guangzhou Tosun Pharmaceutical、Jiangsu Nhwa Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 リスペリドンAPI市場は、種類と用途によって区分されます。世界のリスペリドンAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 98%以上、99%以上 【用途別セグメント】 錠剤、内服液、カプセル剤、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - リスペリドンAPI製品概要 - 種類別市場（98%以上、99%以上） - 用途別市場（錠剤、内服液、カプセル剤、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のリスペリドンAPI販売量予測2017-2028 - 世界のリスペリドンAPI売上予測2017-2028 - リスペリドンAPIの地域別販売量 - リスペリドンAPIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別リスペリドンAPI販売量 - 主要メーカー別リスペリドンAPI売上 - 主要メーカー別リスペリドンAPI価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（98%以上、99%以上） - リスペリドンAPIの種類別販売量 - リスペリドンAPIの種類別売上 - リスペリドンAPIの種類別価格 ・用途別市場規模（錠剤、内服液、カプセル剤、その他） - リスペリドンAPIの用途別販売量 - リスペリドンAPIの用途別売上 - リスペリドンAPIの用途別価格 ・北米市場 - 北米のリスペリドンAPI市場規模（種類別、用途別） - 主要国別のリスペリドンAPI市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのリスペリドンAPI市場規模（種類別、用途別） - 主要国別のリスペリドンAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のリスペリドンAPI市場規模（種類別、用途別） - 主要国別のリスペリドンAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のリスペリドンAPI市場規模（種類別、用途別） - 主要国別のリスペリドンAPI市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのリスペリドンAPI市場規模（種類別、用途別） - 主要国別のリスペリドンAPI市場規模（トルコ、サウジアラビア） ・企業情報 Interquim SA、Inke S.A、Jai Radhe Sales、Dr. Reddy's Laboratories、Mylan、Teva、RPG Life Sciences Ltd.、Wuxi Jida Pharmaceutical Co., Ltd.、Venkata Narayana Active Ingredients、Torrent Pharmaceuticals Limited、Zhejiang Huahai Pharmaceutical、Icrom、Jubilant Generics、Jeil Pharmaceutical Co., Ltd、Aurobindo Pharma Limited、Enaltec Labs Private Limited、Anugraha Chemicals、Otto Brandes、Aurore Life Sciences、Guangzhou Tosun Pharmaceutical、Jiangsu Nhwa Pharmaceutical ・産業チェーン及び販売チャネル分析 - リスペリドンAPIの産業チェーン分析 - リスペリドンAPIの原材料 - リスペリドンAPIの生産プロセス - リスペリドンAPIの販売及びマーケティング - リスペリドンAPIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - リスペリドンAPIの産業動向 - リスペリドンAPIのマーケットドライバー - リスペリドンAPIの課題 - リスペリドンAPIの阻害要因 ・主な調査結果 |
Risperidone(CAS：106266-06-2) is an atypical antipsychotic used to treat schizophrenia and bipolar disorder.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Risperidone API estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Risperidone API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Risperidone API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Risperidone API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Risperidone API include Interquim SA, Inke S.A, Jai Radhe Sales, Dr. Reddy’s Laboratories, Mylan, Teva, RPG Life Sciences Ltd., Wuxi Jida Pharmaceutical Co., Ltd. and Venkata Narayana Active Ingredients, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Risperidone API production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Risperidone API by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Risperidone API manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Risperidone API market. Further, it explains the major drivers and regional dynamics of the global Risperidone API market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Interquim SA
Inke S.A
Jai Radhe Sales
Dr. Reddy’s Laboratories
Mylan
Teva
RPG Life Sciences Ltd.
Wuxi Jida Pharmaceutical Co., Ltd.
Venkata Narayana Active Ingredients
Torrent Pharmaceuticals Limited
Zhejiang Huahai Pharmaceutical
Icrom
Jubilant Generics
Jeil Pharmaceutical Co., Ltd
Aurobindo Pharma Limited
Enaltec Labs Private Limited
Anugraha Chemicals
Otto Brandes
Aurore Life Sciences
Guangzhou Tosun Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Market Segments
This report has explored the key segments: by Purity and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Risperidone API Segment by Purity
Above 98 %
Above 99 %
Risperidone API Segment by Application
Tablets
Oral Solution
Capsules
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Risperidone API production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Risperidone API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Risperidone API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Risperidone API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Risperidone API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Risperidone API sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Risperidone API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Risperidone API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Interquim SA, Inke S.A, Jai Radhe Sales, Dr. Reddy’s Laboratories, Mylan, Teva, RPG Life Sciences Ltd., Wuxi Jida Pharmaceutical Co., Ltd. and Venkata Narayana Active Ingredients, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Risperidone API capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Risperidone API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Risperidone API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by purity, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by purity, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by purity, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by purity, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by purity, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Risperidone API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Risperidone API Product Introduction
1.2 Market by Purity
1.2.1 Global Risperidone API Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Market by Application
1.3.1 Global Risperidone API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Tablets
1.3.3 Oral Solution
1.3.4 Capsules
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Risperidone API Production
2.1 Global Risperidone API Production Capacity (2017-2028)
2.2 Global Risperidone API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Risperidone API Production by Region
2.3.1 Global Risperidone API Historic Production by Region (2017-2022)
2.3.2 Global Risperidone API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 India
2.8 South Korea
2.9 Israel
3 Global Risperidone API Sales in Volume & Value Estimates and Forecasts
3.1 Global Risperidone API Sales Estimates and Forecasts 2017-2028
3.2 Global Risperidone API Revenue Estimates and Forecasts 2017-2028
3.3 Global Risperidone API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Risperidone API Sales by Region
3.4.1 Global Risperidone API Sales by Region (2017-2022)
3.4.2 Global Sales Risperidone API by Region (2023-2028)
3.5 Global Risperidone API Revenue by Region
3.5.1 Global Risperidone API Revenue by Region (2017-2022)
3.5.2 Global Risperidone API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Risperidone API Production Capacity by Manufacturers
4.2 Global Risperidone API Sales by Manufacturers
4.2.1 Global Risperidone API Sales by Manufacturers (2017-2022)
4.2.2 Global Risperidone API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Risperidone API in 2021
4.3 Global Risperidone API Revenue by Manufacturers
4.3.1 Global Risperidone API Revenue by Manufacturers (2017-2022)
4.3.2 Global Risperidone API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Risperidone API Revenue in 2021
4.4 Global Risperidone API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Risperidone API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Risperidone API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global Risperidone API Sales by Purity
5.1.1 Global Risperidone API Historical Sales by Purity (2017-2022)
5.1.2 Global Risperidone API Forecasted Sales by Purity (2023-2028)
5.1.3 Global Risperidone API Sales Market Share by Purity (2017-2028)
5.2 Global Risperidone API Revenue by Purity
5.2.1 Global Risperidone API Historical Revenue by Purity (2017-2022)
5.2.2 Global Risperidone API Forecasted Revenue by Purity (2023-2028)
5.2.3 Global Risperidone API Revenue Market Share by Purity (2017-2028)
5.3 Global Risperidone API Price by Purity
5.3.1 Global Risperidone API Price by Purity (2017-2022)
5.3.2 Global Risperidone API Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global Risperidone API Sales by Application
6.1.1 Global Risperidone API Historical Sales by Application (2017-2022)
6.1.2 Global Risperidone API Forecasted Sales by Application (2023-2028)
6.1.3 Global Risperidone API Sales Market Share by Application (2017-2028)
6.2 Global Risperidone API Revenue by Application
6.2.1 Global Risperidone API Historical Revenue by Application (2017-2022)
6.2.2 Global Risperidone API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Risperidone API Revenue Market Share by Application (2017-2028)
6.3 Global Risperidone API Price by Application
6.3.1 Global Risperidone API Price by Application (2017-2022)
6.3.2 Global Risperidone API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Risperidone API Market Size by Purity
7.1.1 North America Risperidone API Sales by Purity (2017-2028)
7.1.2 North America Risperidone API Revenue by Purity (2017-2028)
7.2 North America Risperidone API Market Size by Application
7.2.1 North America Risperidone API Sales by Application (2017-2028)
7.2.2 North America Risperidone API Revenue by Application (2017-2028)
7.3 North America Risperidone API Sales by Country
7.3.1 North America Risperidone API Sales by Country (2017-2028)
7.3.2 North America Risperidone API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Risperidone API Market Size by Purity
8.1.1 Europe Risperidone API Sales by Purity (2017-2028)
8.1.2 Europe Risperidone API Revenue by Purity (2017-2028)
8.2 Europe Risperidone API Market Size by Application
8.2.1 Europe Risperidone API Sales by Application (2017-2028)
8.2.2 Europe Risperidone API Revenue by Application (2017-2028)
8.3 Europe Risperidone API Sales by Country
8.3.1 Europe Risperidone API Sales by Country (2017-2028)
8.3.2 Europe Risperidone API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Risperidone API Market Size by Purity
9.1.1 Asia Pacific Risperidone API Sales by Purity (2017-2028)
9.1.2 Asia Pacific Risperidone API Revenue by Purity (2017-2028)
9.2 Asia Pacific Risperidone API Market Size by Application
9.2.1 Asia Pacific Risperidone API Sales by Application (2017-2028)
9.2.2 Asia Pacific Risperidone API Revenue by Application (2017-2028)
9.3 Asia Pacific Risperidone API Sales by Region
9.3.1 Asia Pacific Risperidone API Sales by Region (2017-2028)
9.3.2 Asia Pacific Risperidone API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Risperidone API Market Size by Purity
10.1.1 Latin America Risperidone API Sales by Purity (2017-2028)
10.1.2 Latin America Risperidone API Revenue by Purity (2017-2028)
10.2 Latin America Risperidone API Market Size by Application
10.2.1 Latin America Risperidone API Sales by Application (2017-2028)
10.2.2 Latin America Risperidone API Revenue by Application (2017-2028)
10.3 Latin America Risperidone API Sales by Country
10.3.1 Latin America Risperidone API Sales by Country (2017-2028)
10.3.2 Latin America Risperidone API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Risperidone API Market Size by Purity
11.1.1 Middle East and Africa Risperidone API Sales by Purity (2017-2028)
11.1.2 Middle East and Africa Risperidone API Revenue by Purity (2017-2028)
11.2 Middle East and Africa Risperidone API Market Size by Application
11.2.1 Middle East and Africa Risperidone API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Risperidone API Revenue by Application (2017-2028)
11.3 Middle East and Africa Risperidone API Sales by Country
11.3.1 Middle East and Africa Risperidone API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Risperidone API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Interquim SA
12.1.1 Interquim SA Corporation Information
12.1.2 Interquim SA Overview
12.1.3 Interquim SA Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Interquim SA Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Interquim SA Recent Developments
12.2 Inke S.A
12.2.1 Inke S.A Corporation Information
12.2.2 Inke S.A Overview
12.2.3 Inke S.A Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Inke S.A Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Inke S.A Recent Developments
12.3 Jai Radhe Sales
12.3.1 Jai Radhe Sales Corporation Information
12.3.2 Jai Radhe Sales Overview
12.3.3 Jai Radhe Sales Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Jai Radhe Sales Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Jai Radhe Sales Recent Developments
12.4 Dr. Reddy’s Laboratories
12.4.1 Dr. Reddy’s Laboratories Corporation Information
12.4.2 Dr. Reddy’s Laboratories Overview
12.4.3 Dr. Reddy’s Laboratories Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Dr. Reddy’s Laboratories Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Dr. Reddy’s Laboratories Recent Developments
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Overview
12.5.3 Mylan Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Mylan Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Mylan Recent Developments
12.6 Teva
12.6.1 Teva Corporation Information
12.6.2 Teva Overview
12.6.3 Teva Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Teva Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Teva Recent Developments
12.7 RPG Life Sciences Ltd.
12.7.1 RPG Life Sciences Ltd. Corporation Information
12.7.2 RPG Life Sciences Ltd. Overview
12.7.3 RPG Life Sciences Ltd. Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 RPG Life Sciences Ltd. Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 RPG Life Sciences Ltd. Recent Developments
12.8 Wuxi Jida Pharmaceutical Co., Ltd.
12.8.1 Wuxi Jida Pharmaceutical Co., Ltd. Corporation Information
12.8.2 Wuxi Jida Pharmaceutical Co., Ltd. Overview
12.8.3 Wuxi Jida Pharmaceutical Co., Ltd. Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Wuxi Jida Pharmaceutical Co., Ltd. Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Wuxi Jida Pharmaceutical Co., Ltd. Recent Developments
12.9 Venkata Narayana Active Ingredients
12.9.1 Venkata Narayana Active Ingredients Corporation Information
12.9.2 Venkata Narayana Active Ingredients Overview
12.9.3 Venkata Narayana Active Ingredients Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Venkata Narayana Active Ingredients Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Venkata Narayana Active Ingredients Recent Developments
12.10 Torrent Pharmaceuticals Limited
12.10.1 Torrent Pharmaceuticals Limited Corporation Information
12.10.2 Torrent Pharmaceuticals Limited Overview
12.10.3 Torrent Pharmaceuticals Limited Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Torrent Pharmaceuticals Limited Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Torrent Pharmaceuticals Limited Recent Developments
12.11 Zhejiang Huahai Pharmaceutical
12.11.1 Zhejiang Huahai Pharmaceutical Corporation Information
12.11.2 Zhejiang Huahai Pharmaceutical Overview
12.11.3 Zhejiang Huahai Pharmaceutical Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Zhejiang Huahai Pharmaceutical Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Zhejiang Huahai Pharmaceutical Recent Developments
12.12 Icrom
12.12.1 Icrom Corporation Information
12.12.2 Icrom Overview
12.12.3 Icrom Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Icrom Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Icrom Recent Developments
12.13 Jubilant Generics
12.13.1 Jubilant Generics Corporation Information
12.13.2 Jubilant Generics Overview
12.13.3 Jubilant Generics Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Jubilant Generics Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Jubilant Generics Recent Developments
12.14 Jeil Pharmaceutical Co., Ltd
12.14.1 Jeil Pharmaceutical Co., Ltd Corporation Information
12.14.2 Jeil Pharmaceutical Co., Ltd Overview
12.14.3 Jeil Pharmaceutical Co., Ltd Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Jeil Pharmaceutical Co., Ltd Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Jeil Pharmaceutical Co., Ltd Recent Developments
12.15 Aurobindo Pharma Limited
12.15.1 Aurobindo Pharma Limited Corporation Information
12.15.2 Aurobindo Pharma Limited Overview
12.15.3 Aurobindo Pharma Limited Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Aurobindo Pharma Limited Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Aurobindo Pharma Limited Recent Developments
12.16 Enaltec Labs Private Limited
12.16.1 Enaltec Labs Private Limited Corporation Information
12.16.2 Enaltec Labs Private Limited Overview
12.16.3 Enaltec Labs Private Limited Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 Enaltec Labs Private Limited Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Enaltec Labs Private Limited Recent Developments
12.17 Anugraha Chemicals
12.17.1 Anugraha Chemicals Corporation Information
12.17.2 Anugraha Chemicals Overview
12.17.3 Anugraha Chemicals Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.17.4 Anugraha Chemicals Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 Anugraha Chemicals Recent Developments
12.18 Otto Brandes
12.18.1 Otto Brandes Corporation Information
12.18.2 Otto Brandes Overview
12.18.3 Otto Brandes Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.18.4 Otto Brandes Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.18.5 Otto Brandes Recent Developments
12.19 Aurore Life Sciences
12.19.1 Aurore Life Sciences Corporation Information
12.19.2 Aurore Life Sciences Overview
12.19.3 Aurore Life Sciences Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.19.4 Aurore Life Sciences Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.19.5 Aurore Life Sciences Recent Developments
12.20 Guangzhou Tosun Pharmaceutical
12.20.1 Guangzhou Tosun Pharmaceutical Corporation Information
12.20.2 Guangzhou Tosun Pharmaceutical Overview
12.20.3 Guangzhou Tosun Pharmaceutical Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.20.4 Guangzhou Tosun Pharmaceutical Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.20.5 Guangzhou Tosun Pharmaceutical Recent Developments
12.21 Jiangsu Nhwa Pharmaceutical
12.21.1 Jiangsu Nhwa Pharmaceutical Corporation Information
12.21.2 Jiangsu Nhwa Pharmaceutical Overview
12.21.3 Jiangsu Nhwa Pharmaceutical Risperidone API Sales, Price, Revenue and Gross Margin (2017-2022)
12.21.4 Jiangsu Nhwa Pharmaceutical Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
12.21.5 Jiangsu Nhwa Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Risperidone API Industry Chain Analysis
13.2 Risperidone API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Risperidone API Production Mode & Process
13.4 Risperidone API Sales and Marketing
13.4.1 Risperidone API Sales Channels
13.4.2 Risperidone API Distributors
13.5 Risperidone API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Risperidone API Industry Trends
14.2 Risperidone API Market Drivers
14.3 Risperidone API Market Challenges
14.4 Risperidone API Market Restraints
15 Key Finding in The Global Risperidone API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Risperidone API Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Above 98 %
Table 3. Major Manufacturers of Above 99 %
Table 4. Global Risperidone API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Risperidone API Production by Region: 2017 VS 2021 VS 2028 (Kg)
Table 6. Global Risperidone API Production by Region (2017-2022) & (Kg)
Table 7. Global Risperidone API Production Market Share by Region (2017-2022)
Table 8. Global Risperidone API Production by Region (2023-2028) & (Kg)
Table 9. Global Risperidone API Production Market Share by Region (2023-2028)
Table 10. Global Risperidone API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Risperidone API Sales by Region (2017-2022) & (Kg)
Table 12. Global Risperidone API Sales Market Share by Region (2017-2022)
Table 13. Global Risperidone API Sales by Region (2023-2028) & (Kg)
Table 14. Global Risperidone API Sales Market Share by Region (2023-2028)
Table 15. Global Risperidone API Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Risperidone API Revenue Market Share by Region (2017-2022)
Table 17. Global Risperidone API Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Risperidone API Revenue Market Share by Region (2023-2028)
Table 19. Global Risperidone API Production Capacity by Manufacturers (2017-2022) & (Kg)
Table 20. Global Risperidone API Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Risperidone API Sales by Manufacturers (2017-2022) & (Kg)
Table 22. Global Risperidone API Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Risperidone API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Risperidone API Revenue Share by Manufacturers (2017-2022)
Table 25. Risperidone API Price by Manufacturers 2017-2022 (US$/Kg)
Table 26. Global Risperidone API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Risperidone API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Risperidone API as of 2021)
Table 28. Risperidone API Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Risperidone API Product Offered
Table 30. Date of Manufacturers Enter into Risperidone API Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Risperidone API Sales by Purity (2017-2022) & (Kg)
Table 33. Global Risperidone API Sales by Purity (2023-2028) & (Kg)
Table 34. Global Risperidone API Sales Share by Purity (2017-2022)
Table 35. Global Risperidone API Sales Share by Purity (2023-2028)
Table 36. Global Risperidone API Revenue by Purity (2017-2022) & (US$ Million)
Table 37. Global Risperidone API Revenue by Purity (2023-2028) & (US$ Million)
Table 38. Global Risperidone API Revenue Share by Purity (2017-2022)
Table 39. Global Risperidone API Revenue Share by Purity (2023-2028)
Table 40. Risperidone API Price by Purity (2017-2022) & (US$/Kg)
Table 41. Global Risperidone API Price Forecast by Purity (2023-2028) & (US$/Kg)
Table 42. Global Risperidone API Sales by Application (2017-2022) & (Kg)
Table 43. Global Risperidone API Sales by Application (2023-2028) & (Kg)
Table 44. Global Risperidone API Sales Share by Application (2017-2022)
Table 45. Global Risperidone API Sales Share by Application (2023-2028)
Table 46. Global Risperidone API Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Risperidone API Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Risperidone API Revenue Share by Application (2017-2022)
Table 49. Global Risperidone API Revenue Share by Application (2023-2028)
Table 50. Risperidone API Price by Application (2017-2022) & (US$/Kg)
Table 51. Global Risperidone API Price Forecast by Application (2023-2028) & (US$/Kg)
Table 52. North America Risperidone API Sales by Purity (2017-2022) & (Kg)
Table 53. North America Risperidone API Sales by Purity (2023-2028) & (Kg)
Table 54. North America Risperidone API Revenue by Purity (2017-2022) & (US$ Million)
Table 55. North America Risperidone API Revenue by Purity (2023-2028) & (US$ Million)
Table 56. North America Risperidone API Sales by Application (2017-2022) & (Kg)
Table 57. North America Risperidone API Sales by Application (2023-2028) & (Kg)
Table 58. North America Risperidone API Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Risperidone API Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Risperidone API Sales by Country (2017-2022) & (Kg)
Table 61. North America Risperidone API Sales by Country (2023-2028) & (Kg)
Table 62. North America Risperidone API Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Risperidone API Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Risperidone API Sales by Purity (2017-2022) & (Kg)
Table 65. Europe Risperidone API Sales by Purity (2023-2028) & (Kg)
Table 66. Europe Risperidone API Revenue by Purity (2017-2022) & (US$ Million)
Table 67. Europe Risperidone API Revenue by Purity (2023-2028) & (US$ Million)
Table 68. Europe Risperidone API Sales by Application (2017-2022) & (Kg)
Table 69. Europe Risperidone API Sales by Application (2023-2028) & (Kg)
Table 70. Europe Risperidone API Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Risperidone API Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Risperidone API Sales by Country (2017-2022) & (Kg)
Table 73. Europe Risperidone API Sales by Country (2023-2028) & (Kg)
Table 74. Europe Risperidone API Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Risperidone API Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Risperidone API Sales by Purity (2017-2022) & (Kg)
Table 77. Asia Pacific Risperidone API Sales by Purity (2023-2028) & (Kg)
Table 78. Asia Pacific Risperidone API Revenue by Purity (2017-2022) & (US$ Million)
Table 79. Asia Pacific Risperidone API Revenue by Purity (2023-2028) & (US$ Million)
Table 80. Asia Pacific Risperidone API Sales by Application (2017-2022) & (Kg)
Table 81. Asia Pacific Risperidone API Sales by Application (2023-2028) & (Kg)
Table 82. Asia Pacific Risperidone API Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Risperidone API Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Risperidone API Sales by Region (2017-2022) & (Kg)
Table 85. Asia Pacific Risperidone API Sales by Region (2023-2028) & (Kg)
Table 86. Asia Pacific Risperidone API Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Risperidone API Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Risperidone API Sales by Purity (2017-2022) & (Kg)
Table 89. Latin America Risperidone API Sales by Purity (2023-2028) & (Kg)
Table 90. Latin America Risperidone API Revenue by Purity (2017-2022) & (US$ Million)
Table 91. Latin America Risperidone API Revenue by Purity (2023-2028) & (US$ Million)
Table 92. Latin America Risperidone API Sales by Application (2017-2022) & (Kg)
Table 93. Latin America Risperidone API Sales by Application (2023-2028) & (Kg)
Table 94. Latin America Risperidone API Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Risperidone API Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Risperidone API Sales by Country (2017-2022) & (Kg)
Table 97. Latin America Risperidone API Sales by Country (2023-2028) & (Kg)
Table 98. Latin America Risperidone API Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Risperidone API Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Risperidone API Sales by Purity (2017-2022) & (Kg)
Table 101. Middle East and Africa Risperidone API Sales by Purity (2023-2028) & (Kg)
Table 102. Middle East and Africa Risperidone API Revenue by Purity (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Risperidone API Revenue by Purity (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Risperidone API Sales by Application (2017-2022) & (Kg)
Table 105. Middle East and Africa Risperidone API Sales by Application (2023-2028) & (Kg)
Table 106. Middle East and Africa Risperidone API Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Risperidone API Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Risperidone API Sales by Country (2017-2022) & (Kg)
Table 109. Middle East and Africa Risperidone API Sales by Country (2023-2028) & (Kg)
Table 110. Middle East and Africa Risperidone API Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Risperidone API Revenue by Country (2023-2028) & (US$ Million)
Table 112. Interquim SA Corporation Information
Table 113. Interquim SA Description and Major Businesses
Table 114. Interquim SA Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 115. Interquim SA Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Interquim SA Recent Development
Table 117. Inke S.A Corporation Information
Table 118. Inke S.A Description and Major Businesses
Table 119. Inke S.A Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 120. Inke S.A Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Inke S.A Recent Development
Table 122. Jai Radhe Sales Corporation Information
Table 123. Jai Radhe Sales Description and Major Businesses
Table 124. Jai Radhe Sales Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 125. Jai Radhe Sales Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Jai Radhe Sales Recent Development
Table 127. Dr. Reddy's Laboratories Corporation Information
Table 128. Dr. Reddy's Laboratories Description and Major Businesses
Table 129. Dr. Reddy's Laboratories Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 130. Dr. Reddy's Laboratories Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Dr. Reddy's Laboratories Recent Development
Table 132. Mylan Corporation Information
Table 133. Mylan Description and Major Businesses
Table 134. Mylan Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 135. Mylan Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Mylan Recent Development
Table 137. Teva Corporation Information
Table 138. Teva Description and Major Businesses
Table 139. Teva Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 140. Teva Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Teva Recent Development
Table 142. RPG Life Sciences Ltd. Corporation Information
Table 143. RPG Life Sciences Ltd. Description and Major Businesses
Table 144. RPG Life Sciences Ltd. Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 145. RPG Life Sciences Ltd. Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. RPG Life Sciences Ltd. Recent Development
Table 147. Wuxi Jida Pharmaceutical Co., Ltd. Corporation Information
Table 148. Wuxi Jida Pharmaceutical Co., Ltd. Description and Major Businesses
Table 149. Wuxi Jida Pharmaceutical Co., Ltd. Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 150. Wuxi Jida Pharmaceutical Co., Ltd. Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Wuxi Jida Pharmaceutical Co., Ltd. Recent Development
Table 152. Venkata Narayana Active Ingredients Corporation Information
Table 153. Venkata Narayana Active Ingredients Description and Major Businesses
Table 154. Venkata Narayana Active Ingredients Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 155. Venkata Narayana Active Ingredients Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Venkata Narayana Active Ingredients Recent Development
Table 157. Torrent Pharmaceuticals Limited Corporation Information
Table 158. Torrent Pharmaceuticals Limited Description and Major Businesses
Table 159. Torrent Pharmaceuticals Limited Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 160. Torrent Pharmaceuticals Limited Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Torrent Pharmaceuticals Limited Recent Development
Table 162. Zhejiang Huahai Pharmaceutical Corporation Information
Table 163. Zhejiang Huahai Pharmaceutical Description and Major Businesses
Table 164. Zhejiang Huahai Pharmaceutical Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 165. Zhejiang Huahai Pharmaceutical Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Zhejiang Huahai Pharmaceutical Recent Development
Table 167. Icrom Corporation Information
Table 168. Icrom Description and Major Businesses
Table 169. Icrom Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 170. Icrom Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Icrom Recent Development
Table 172. Jubilant Generics Corporation Information
Table 173. Jubilant Generics Description and Major Businesses
Table 174. Jubilant Generics Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 175. Jubilant Generics Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Jubilant Generics Recent Development
Table 177. Jeil Pharmaceutical Co., Ltd Corporation Information
Table 178. Jeil Pharmaceutical Co., Ltd Description and Major Businesses
Table 179. Jeil Pharmaceutical Co., Ltd Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 180. Jeil Pharmaceutical Co., Ltd Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Jeil Pharmaceutical Co., Ltd Recent Development
Table 182. Aurobindo Pharma Limited Corporation Information
Table 183. Aurobindo Pharma Limited Description and Major Businesses
Table 184. Aurobindo Pharma Limited Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 185. Aurobindo Pharma Limited Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Aurobindo Pharma Limited Recent Development
Table 187. Enaltec Labs Private Limited Corporation Information
Table 188. Enaltec Labs Private Limited Description and Major Businesses
Table 189. Enaltec Labs Private Limited Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 190. Enaltec Labs Private Limited Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Enaltec Labs Private Limited Recent Development
Table 192. Anugraha Chemicals Corporation Information
Table 193. Anugraha Chemicals Description and Major Businesses
Table 194. Anugraha Chemicals Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 195. Anugraha Chemicals Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Anugraha Chemicals Recent Development
Table 197. Otto Brandes Corporation Information
Table 198. Otto Brandes Description and Major Businesses
Table 199. Otto Brandes Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 200. Otto Brandes Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Otto Brandes Recent Development
Table 202. Aurore Life Sciences Corporation Information
Table 203. Aurore Life Sciences Description and Major Businesses
Table 204. Aurore Life Sciences Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 205. Aurore Life Sciences Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. Aurore Life Sciences Recent Development
Table 207. Guangzhou Tosun Pharmaceutical Corporation Information
Table 208. Guangzhou Tosun Pharmaceutical Description and Major Businesses
Table 209. Guangzhou Tosun Pharmaceutical Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 210. Guangzhou Tosun Pharmaceutical Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 211. Guangzhou Tosun Pharmaceutical Recent Development
Table 212. Jiangsu Nhwa Pharmaceutical Corporation Information
Table 213. Jiangsu Nhwa Pharmaceutical Description and Major Businesses
Table 214. Jiangsu Nhwa Pharmaceutical Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 215. Jiangsu Nhwa Pharmaceutical Risperidone API Product Model Numbers, Pictures, Descriptions and Specifications
Table 216. Jiangsu Nhwa Pharmaceutical Recent Development
Table 217. Key Raw Materials Lists
Table 218. Raw Materials Key Suppliers Lists
Table 219. Risperidone API Distributors List
Table 220. Risperidone API Customers List
Table 221. Risperidone API Market Trends
Table 222. Risperidone API Market Drivers
Table 223. Risperidone API Market Challenges
Table 224. Risperidone API Market Restraints
Table 225. Research Programs/Design for This Report
Table 226. Key Data Information from Secondary Sources
Table 227. Key Data Information from Primary Sources
List of Figures
Figure 1. Risperidone API Product Picture
Figure 2. Global Risperidone API Market Share by Purity in 2021 & 2028
Figure 3. Above 98 % Product Picture
Figure 4. Above 99 % Product Picture
Figure 5. Global Risperidone API Market Share by Application in 2021 & 2028
Figure 6. Tablets
Figure 7. Oral Solution
Figure 8. Capsules
Figure 9. Others
Figure 10. Risperidone API Report Years Considered
Figure 11. Global Risperidone API Capacity, Production and Utilization (2017-2028) & (Kg)
Figure 12. Global Risperidone API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Risperidone API Production Market Share by Region (2017-2022)
Figure 14. Global Risperidone API Production Market Share by Region (2023-2028)
Figure 15. Risperidone API Production Growth Rate in North America (2017-2028) & (Kg)
Figure 16. Risperidone API Production Growth Rate in Europe (2017-2028) & (Kg)
Figure 17. Risperidone API Production Growth Rate in China (2017-2028) & (Kg)
Figure 18. Risperidone API Production Growth Rate in India (2017-2028) & (Kg)
Figure 19. Risperidone API Production Growth Rate in South Korea (2017-2028) & (Kg)
Figure 20. Risperidone API Production Growth Rate in Israel (2017-2028) & (Kg)
Figure 21. Global Risperidone API Sales 2017-2028 (Kg)
Figure 22. Global Risperidone API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 23. Global Risperidone API Revenue 2017-2028 (US$ Million)
Figure 24. Global Risperidone API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 25. Global Risperidone API Sales Market Share by Region (2017-2022)
Figure 26. Global Risperidone API Sales Market Share by Region (2023-2028)
Figure 27. North America Risperidone API Sales YoY (2017-2028) & (Kg)
Figure 28. North America Risperidone API Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Europe Risperidone API Sales YoY (2017-2028) & (Kg)
Figure 30. Europe Risperidone API Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Risperidone API Sales YoY (2017-2028) & (Kg)
Figure 32. Asia-Pacific Risperidone API Revenue YoY (2017-2028) & (US$ Million)
Figure 33. Latin America Risperidone API Sales YoY (2017-2028) & (Kg)
Figure 34. Latin America Risperidone API Revenue YoY (2017-2028) & (US$ Million)
Figure 35. Middle East & Africa Risperidone API Sales YoY (2017-2028) & (Kg)
Figure 36. Middle East & Africa Risperidone API Revenue YoY (2017-2028) & (US$ Million)
Figure 37. The Risperidone API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 38. The Top 5 and 10 Largest Manufacturers of Risperidone API in the World: Market Share by Risperidone API Revenue in 2021
Figure 39. Risperidone API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 40. Global Risperidone API Sales Market Share by Purity (2017-2028)
Figure 41. Global Risperidone API Revenue Market Share by Purity (2017-2028)
Figure 42. Global Risperidone API Sales Market Share by Application (2017-2028)
Figure 43. Global Risperidone API Revenue Market Share by Application (2017-2028)
Figure 44. North America Risperidone API Sales Market Share by Purity (2017-2028)
Figure 45. North America Risperidone API Revenue Market Share by Purity (2017-2028)
Figure 46. North America Risperidone API Sales Market Share by Application (2017-2028)
Figure 47. North America Risperidone API Revenue Market Share by Application (2017-2028)
Figure 48. North America Risperidone API Sales Share by Country (2017-2028)
Figure 49. North America Risperidone API Revenue Share by Country (2017-2028)
Figure 50. United States Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 51. Canada Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 52. Europe Risperidone API Sales Market Share by Purity (2017-2028)
Figure 53. Europe Risperidone API Revenue Market Share by Purity (2017-2028)
Figure 54. Europe Risperidone API Sales Market Share by Application (2017-2028)
Figure 55. Europe Risperidone API Revenue Market Share by Application (2017-2028)
Figure 56. Europe Risperidone API Sales Share by Country (2017-2028)
Figure 57. Europe Risperidone API Revenue Share by Country (2017-2028)
Figure 58. Germany Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 59. France Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 60. U.K. Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 61. Italy Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 62. Russia Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 63. Asia Pacific Risperidone API Sales Market Share by Purity (2017-2028)
Figure 64. Asia Pacific Risperidone API Revenue Market Share by Purity (2017-2028)
Figure 65. Asia Pacific Risperidone API Sales Market Share by Application (2017-2028)
Figure 66. Asia Pacific Risperidone API Revenue Market Share by Application (2017-2028)
Figure 67. Asia Pacific Risperidone API Sales Share by Region (2017-2028)
Figure 68. Asia Pacific Risperidone API Revenue Share by Region (2017-2028)
Figure 69. China Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 70. Japan Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 71. South Korea Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 72. India Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 73. Australia Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 74. China Taiwan Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 75. Indonesia Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 76. Thailand Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 77. Malaysia Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 78. Latin America Risperidone API Sales Market Share by Purity (2017-2028)
Figure 79. Latin America Risperidone API Revenue Market Share by Purity (2017-2028)
Figure 80. Latin America Risperidone API Sales Market Share by Application (2017-2028)
Figure 81. Latin America Risperidone API Revenue Market Share by Application (2017-2028)
Figure 82. Latin America Risperidone API Sales Share by Country (2017-2028)
Figure 83. Latin America Risperidone API Revenue Share by Country (2017-2028)
Figure 84. Mexico Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 85. Brazil Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 86. Argentina Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 87. Colombia Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 88. Middle East and Africa Risperidone API Sales Market Share by Purity (2017-2028)
Figure 89. Middle East and Africa Risperidone API Revenue Market Share by Purity (2017-2028)
Figure 90. Middle East and Africa Risperidone API Sales Market Share by Application (2017-2028)
Figure 91. Middle East and Africa Risperidone API Revenue Market Share by Application (2017-2028)
Figure 92. Middle East and Africa Risperidone API Sales Share by Country (2017-2028)
Figure 93. Middle East and Africa Risperidone API Revenue Share by Country (2017-2028)
Figure 94. Turkey Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 95. Saudi Arabia Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 96. UAE Risperidone API Revenue (2017-2028) & (US$ Million)
Figure 97. Risperidone API Value Chain
Figure 98. Risperidone API Production Process
Figure 99. Channels of Distribution
Figure 100. Distributors Profiles
Figure 101. Bottom-up and Top-down Approaches for This Report
Figure 102. Data Triangulation
Figure 103. Key Executives Interviewed